484 results on '"Déglon, Nicole"'
Search Results
2. Disruption of Astrocyte-Dependent Dopamine Control in the Developing Medial Prefrontal Cortex Leads to Excessive Grooming in Mice
3. Tau promotes oxidative stress-associated cycling neurons in S phase as a pro-survival mechanism: Possible implication for Alzheimer’s disease
4. Lactate transporters in the rat barrel cortex sustain whisker-dependent BOLD fMRI signal and behavioral performance
5. Extracellular vesicles: Major actors of heterogeneity in tau spreading among human tauopathies
6. Neuronal A2A receptor exacerbates synapse loss and memory deficits in APP/PS1 mice.
7. Revisiting the outcome of adult wild-type Htt inactivation in the context of HTT-lowering strategies for Huntington’s disease
8. Maximizing lentiviral vector gene transfer in the CNS
9. Tau accumulation in astrocytes of the dentate gyrus induces neuronal dysfunction and memory deficits in Alzheimer’s disease
10. Limitations of Dual-Single Guide RNA CRISPR Strategies for the Treatment of Central Nervous System Genetic Disorders
11. Glucose metabolism links astroglial mitochondria to cannabinoid effects
12. Dysfunction of homeostatic control of dopamine by astrocytes in the developing prefrontal cortex leads to cognitive impairments
13. Correction: Maximizing lentiviral vector gene transfer in the CNS
14. Tau Transfer via Extracellular Vesicles Disturbs the Astrocytic Mitochondrial System
15. Lentiviral mediated RPE65 gene transfer in healthy hiPSCs-derived retinal pigment epithelial cells markedly increased RPE65 mRNA, but modestly protein level
16. Grafts of Adenosine-Releasing Cells Suppress Seizures in Kindling Epilepsy
17. A New Tool for In Vivo Study of Astrocyte Connexin 43 in Brain
18. Neurodegeneration Prevented by Lentiviral Vector Delivery of GDNF in Primate Models of Parkinson's Disease
19. Accumulation of Tau in Extracellular Vesicles Disturbs the Astrocytic Mitochondrial System
20. Scalable Production and Purification of Adeno-Associated Viral Vectors (AAV)
21. CRISPR/Cas9-Mediated Genome Editing for Huntington’s Disease
22. Different tau species lead to heterogeneous tau pathology propagation and misfolding
23. Central Nervous System Gene Therapy: Present Developments and Emerging Trends Accelerating Industry-Academia Pathways
24. SET translocation is associated with increase in caspase cleaved amyloid precursor protein in CA1 of Alzheimer and Down syndrome patients
25. List of Contributors
26. From huntingtin gene to Huntington’s disease-altering strategies
27. Extracellular vesicles: major actors of heterogeneity in tau spreading among human tauopathies
28. Thrombolysis by PLAT/tPA increases serum free IGF1 leading to a decrease of deleterious autophagy following brain ischemia
29. Connexin 30 sets synaptic strength by controlling astroglial synapse invasion
30. Loss of the thyroid hormone-binding protein Crym renders striatal neurons more vulnerable to mutant huntingtin in Huntingtonʼs disease
31. Human Induced Pluripotent Stem Cell-Derived Astrocytes Are Differentially Activated by Multiple Sclerosis-Associated Cytokines
32. Thrombolysis by PLAT/tPA increases serum free IGF1 leading to a decrease of deleterious autophagy following brain ischemia.
33. Overexpression of Mutant Ataxin-3 in Mouse Cerebellum Induces Ataxia and Cerebellar Neuropathology
34. Corrigendum: Genome Editing for CNS Disorders
35. Mitochondrial biogenesis in developing astrocytes regulates astrocyte maturation and synapse formation
36. Lentiviral Vectors in Huntington’s Disease Research and Therapy
37. Astrocytic VMAT2 in the developing prefrontal cortex is required for normal grooming behavior in mice
38. A role of mitochondrial complex II defects in genetic models of Huntingtonʼs disease expressing N-terminal fragments of mutant huntingtin
39. The striatal long noncoding RNA Abhd11os is neuroprotective against an N-terminal fragment of mutant huntingtin in vivo
40. Lentiviral-Mediated Gene Transfer of siRNAs for the Treatment of Huntington’s Disease
41. Metabolic correction in oligodendrocytes derived from metachromatic leukodystrophy mouse model by using encapsulated recombinant myoblasts
42. A3-2 MicroRNAs detargeting technology in the context of CNS applications
43. Genome Editing for CNS Disorders
44. Beclin 1 mitigates motor and neuropathological deficits in genetic mouse models of Machado–Joseph disease
45. Lentivirus-mediated expression of glutathione peroxidase: Neuroprotection in murine models of Parkinson's disease
46. Calpastatin-mediated inhibition of calpains in the mouse brain prevents mutant ataxin 3 proteolysis, nuclear localization and aggregation, relieving Machado–Joseph disease
47. Gene Transfer Techniques for the Delivery of GDNF in Parkinson's Disease
48. Overexpression of the autophagic beclin-1 protein clears mutant ataxin-3 and alleviates Machado–Joseph disease
49. Maximizing lentiviral vector gene transfer in the CNS
50. Efficacy of THN201, a Combination of Donepezil and Mefloquine, to Reverse Neurocognitive Deficits in Alzheimer’s Disease
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.